PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
2024-04-19 2:07:04 PM | Chg. 0.000 | Volume | Bid3:58:49 PM | Ask2:07:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.000EUR | 0.00% | 481 Turnover: 10,668.600 |
22.000Bid Size: 100 | 22.400Ask Size: 340 | 264 mill.EUR | 2.05% | 24.72 |
Assets
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
---|---|---|---|---|---|
Property and Equipment | .4000 | .4000 | |||
Intangible Assets | 1.8000 | 82.2000 | |||
Long-Term Investments | .0600 | 0.0000 | |||
Fixed Assets | - | - | |||
Inventories | 3 | 4.2000 | |||
Accounts Receivable | - | - | |||
Cash and Cash Equivalents | 8 | 20.8000 | |||
Current Assets | 22.4000 | 32.5000 | |||
Total Assets | 24.9000 | 115.3000 |
Liabilities
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
---|---|---|---|---|---|
Accounts Payable | 9.8000 | 4.5000 | |||
Long-term debt | - | - | |||
Liabilities to Banks | 1.2000 | 85.7000 | |||
Provisions | 1 | 1.2000 | |||
Liabilities | 13.4000 | 93 | |||
Share Capital | - | - | |||
Total Equity | 11.5070 | 22.1970 | |||
Minority Interests | - | - | |||
Total liabilities equity | 24.9000 | 115.3000 |
Income Statement
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
---|---|---|---|---|---|
Revenues | 63.2000 | 65.3000 | |||
Depreciation (total) | .5000 | 3.6000 | |||
Operating Result | 14.2000 | 14.9000 | |||
Interest Income | -.0900 | -.7000 | |||
Income Before Taxes | 14.1000 | 14.2000 | |||
Income Taxes | 3.5000 | 3.5000 | |||
Minority Interests Profit | - | - | |||
Net Income | 10.6000 | 10.7000 |
Per Share
Cash Flow
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
---|---|---|---|---|---|
Cash Flow from Operating Activities | 15.5000 | 12.2000 | |||
Cash Flow from Investing Activities | -.9000 | -83.5000 | |||
Cash Flow from Financing | -95 | 84 | |||
Decrease / Increase in Cash | -80.5000 | 12.8000 | |||
Employees | 60 | 75 |